Autopsy report · NCT00866034

Cetrotide Treatment Optimization

“Due to limited rate of patient inclusion”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 3 years 8 months before it stopped.
• 617 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Bart CJM Fauser

Sponsor type

University, hospital or other

Conditions

In Vitro Fertilization; Intracytoplasmic Sperm Injection

Interventions

Cetrotide (Ovarian stimulation); Cetrotide (Ovarian stimulation)

Participants

617

Sites

1

Countries

Netherlands

Trials that died the same way

• Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
  “Due to slow inclusion of patients” (79% match in meaning)
• Exercise for Improving Prostate Oxygenation in Prostate Tumors (Exipox)
  “Slow inclusion rate due to patients operated before intervention is implementable” (77% match in meaning)
• Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions
  “Not enough eligible patients available” (75% match in meaning)
• Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
  “Less patients than expected for inclusion, therefore recruitment is too low” (74% match in meaning)
• Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
  “Too narrow inclusion criteria. Impossible to recruit patients.” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.